ASTEX THERAPEUTICS LIMITED
Company Information
- Company Number
- 03751674
- Registered Address
- 436 Cambridge Science Park, Milton Road, Cambridge, CB4 0QA
- Status
- Active
- Employee Count
- 166
- Turnover
- £202,456,000
- EBITDA
- £145,893,000
Additional Details
- Website
- https://astx.com
- Company Type
- Private limited Company
- Incorporated On
- 14 April 1999
- Nature of Business
- 72110 - Research and experimental development on biotechnology
- Industries
- Life Sciences And Medical Technology
- Region
- East of England
Time to Pay
Payment Timeline
Payment Features
Payment Score History
Performance Reports History
| Reporting Period | Filing Date | Average Time to Pay (days) | Paid within 30 days | Paid 31-60 days | Paid after 60 days | Not Paid within Terms |
|---|---|---|---|---|---|---|
| 01 Jan 2025 - 30 Jun 2025 | 23 Jul 2025 | 14 | 95% | 4% | 1% | 1% |
| 01 Jul 2024 - 31 Dec 2024 | 11 Apr 2025 | 14 | 95% | 4% | 1% | 5% |
| 01 Jul 2023 - 31 Dec 2023 | 30 Jan 2024 | 14 | 93% | 6% | 1% | 19% |
| 01 Jul 2022 - 31 Dec 2022 | 17 Jan 2023 | 13 | 95% | 4% | 1% | 15% |
| 01 Jan 2022 - 30 Jun 2022 | 21 Jul 2022 | 13 | 96% | 3% | 1% | 13% |
| 01 Jul 2021 - 31 Dec 2021 | 21 Jan 2022 | 15 | 93% | 6% | 1% | 17% |
| 01 Jan 2021 - 30 Jun 2021 | 14 Jul 2021 | 18 | 89% | 10% | 1% | 21% |
| 01 Jul 2020 - 31 Dec 2020 | 21 Jan 2021 | 20 | 81% | 18% | 1% | 27% |
| 01 Jan 2019 - 30 Jun 2019 | 24 Jul 2019 | 16 | 94% | 4% | 2% | 16% |
| 01 Jul 2018 - 31 Dec 2018 | 21 Jan 2019 | 18 | 89% | 9% | 2% | 21% |
| 01 Jan 2018 - 30 Jun 2018 | 02 Aug 2018 | 18 | 92% | 7% | 1% | 21% |
Payment Time Trends
Payment Distribution Trends
Invoice Payment Practices
This information is as reported by the business, and responses are in their own words.
Payment Terms
Standard payment terms
General payment terms are within 30 days
Were there any changes to the standard payment terms in the reporting period?
No information available
Any other information about payment terms
No additional information
Maximum contractual payment period agreed
30
Dispute Resolution Process
Complaints or concerns will be considered by the Finance Department, out contract details and payment terms are detailed on our purchase orders.
Other Payment Information
Has this business signed up to a code of conduct or standards on payment practices?
For example, signatories to The Prompt Payment Code must commit to paying 95% of their invoices within 60 days.
❌
Does this business offer e-invoicing in relation to qualifying contracts?
This is where suppliers can electronically submit and track invoices. It's not just allowing suppliers to email them an invoice.
❌
Does this business offer supply chain finance?
This is where a supplier who has submitted an invoice can be paid by a third-party finance provider earlier than the agreed payment date. The business would then pay the finance provider the invoiced sum.
❌
Under its payment practices and policies, can this business deduct sums from payments under qualifying contracts as a charge for remaining on a supplier list?
❌
During the reporting period, did the business deduct sums from payments as a charge for remaining on a supplier list?
No information available
Company Summary
ASTEX THERAPEUTICS LIMITED is a UK-based biopharmaceutical company that focuses on the discovery and development of innovative small molecule drugs to treat cancer and other diseases. The company was founded in 1999 and is headquartered in Cambridge, UK.
The company's sustainability program is centered on reducing its environmental impact and promoting sustainable practices. This includes using renewable energy sources, implementing waste reduction and recycling initiatives, and minimizing water consumption. ASTEX also prioritizes ethical sourcing and responsible business practices in its supply chain.
ASTEX's main products and services include drug discovery and development, as well as collaborations and partnerships with other companies and academic institutions. The company's drug development pipeline includes potential treatments for a range of cancers, including acute myeloid leukemia and solid tumors.
Key people at ASTEX THERAPEUTICS LIMITED include the CEO Harren Jhoti, who co-founded the company, and the Chief Scientific Officer and President James Lorens. The company also has a team of experienced scientists and researchers who are dedicated to advancing its drug development programs.
ASTEX THERAPEUTICS LIMITED can be contacted through their website at www.astex-therapeutics.com or via their registered office address at 436 Cambridge Science Park, Milton Road, Cambridge CB4 0QA, UK. The company's website provides information on its products, pipeline, and collaborations, as well as career opportunities and news updates.
